{"id":"https://openalex.org/W4417005232","doi":"https://doi.org/10.1182/blood-2025-7327","title":"Prognostic significance of pretreatment neutrophil-to- lymphocyte ratio for overall survival in primary myelofibrosis:updated data from Azerbaijan.","display_name":"Prognostic significance of pretreatment neutrophil-to- lymphocyte ratio for overall survival in primary myelofibrosis:updated data from Azerbaijan.","publication_year":2025,"publication_date":"2025-11-03","ids":{"openalex":"https://openalex.org/W4417005232","doi":"https://doi.org/10.1182/blood-2025-7327"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2025-7327","doi":"https://doi.org/10.1182/blood-2025-7327","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-7327","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/7327/2464151/blood-10074-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/7327/2464151/blood-10074-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5096741044","display_name":"Elmir Guluyev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elmir Guluyev","raw_affiliation_strings":["1Main Clinical Hospital of the Ministry of Defense of Azerbaijan, Hematology, Baku, Azerbaijan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Main Clinical Hospital of the Ministry of Defense of Azerbaijan, Hematology, Baku, Azerbaijan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052260890","display_name":"Meded Abbasov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meded Abbasov","raw_affiliation_strings":["1Main Clinical Hospital of the Ministry of Defense of Azerbaijan, Hematology, Baku, Azerbaijan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Main Clinical Hospital of the Ministry of Defense of Azerbaijan, Hematology, Baku, Azerbaijan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118810199","display_name":"Gulnar Garayeva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282907","display_name":"Milli Hematologiya v\u0259 Transfuziologiya M\u0259rk\u0259zi","ror":"https://ror.org/00n6xnd81","country_code":"AZ","type":"healthcare","lineage":["https://openalex.org/I4210144247","https://openalex.org/I4405282907"]}],"countries":["AZ"],"is_corresponding":false,"raw_author_name":"Gulnar Garayeva","raw_affiliation_strings":["2National Hematology and Transfusiology Center, Baku, Azerbaijan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Hematology and Transfusiology Center, Baku, Azerbaijan","institution_ids":["https://openalex.org/I4405282907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049541585","display_name":"Azer Kerimov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282907","display_name":"Milli Hematologiya v\u0259 Transfuziologiya M\u0259rk\u0259zi","ror":"https://ror.org/00n6xnd81","country_code":"AZ","type":"healthcare","lineage":["https://openalex.org/I4210144247","https://openalex.org/I4405282907"]}],"countries":["AZ"],"is_corresponding":false,"raw_author_name":"Azer Kerimov","raw_affiliation_strings":["2National Hematology and Transfusiology Center, Baku, Azerbaijan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2National Hematology and Transfusiology Center, Baku, Azerbaijan","institution_ids":["https://openalex.org/I4405282907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"146","issue":"Supplement 1","first_page":"7327","last_page":"7327"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.5640000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.5640000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.43160000443458557,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":1.0},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.7099999785423279},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.968999981880188},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6980000138282776},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/chronic-inflammation","display_name":"chronic inflammation","score":0.6700000166893005},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.75},{"id":"https://openalex.org/keywords/white-blood-cell-count","display_name":"white blood cell count","score":0.7379999756813049},{"id":"https://openalex.org/keywords/prognostic-cutoff-values","display_name":"prognostic cutoff values","score":0.6980000138282776},{"id":"https://openalex.org/keywords/survival-analysis","display_name":"survival analysis","score":0.5180000066757202},{"id":"https://openalex.org/keywords/receiver-operating-characteristic","display_name":"receiver operating characteristic","score":0.4749999940395355},{"id":"https://openalex.org/keywords/cox-proportional-hazards-model","display_name":"Cox proportional hazards model","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8877000212669373},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.718500018119812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7032999992370605},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.6258000135421753},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6144000291824341},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.48019999265670776},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.46950000524520874},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4650000035762787},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.43950000405311584},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42800000309944153},{"id":"https://openalex.org/C66339696","wikidata":"https://www.wikidata.org/wiki/Q6089397","display_name":"Log-rank test","level":3,"score":0.42669999599456787},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.42399999499320984},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.41350001096725464},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.4043999910354614},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.3790999948978424},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.34689998626708984},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.321399986743927},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3163999915122986},{"id":"https://openalex.org/C164465091","wikidata":"https://www.wikidata.org/wiki/Q7248371","display_name":"Prognostic variable","level":3,"score":0.3046000003814697},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.29660001397132874},{"id":"https://openalex.org/C2779709957","wikidata":"https://www.wikidata.org/wiki/Q17093208","display_name":"Median follow-up","level":3,"score":0.2921999990940094},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.273499995470047},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.27219998836517334},{"id":"https://openalex.org/C198433322","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value of tests","level":2,"score":0.2718999981880188},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.27090001106262207},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.2702000141143799},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.25600001215934753},{"id":"https://openalex.org/C2779788118","wikidata":"https://www.wikidata.org/wiki/Q1542410","display_name":"Thrombocytosis","level":3,"score":0.2540000081062317}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2025-7327","doi":"https://doi.org/10.1182/blood-2025-7327","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-7327","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/7327/2464151/blood-10074-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2025-7327","doi":"https://doi.org/10.1182/blood-2025-7327","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-7327","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/7327/2464151/blood-10074-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4417005232.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413791683","https://openalex.org/W2963465710","https://openalex.org/W4310119504","https://openalex.org/W7093121965","https://openalex.org/W7093121310","https://openalex.org/W7124321084","https://openalex.org/W2911138607","https://openalex.org/W4391685834","https://openalex.org/W4287605433","https://openalex.org/W3120310999"],"abstract_inverted_index":{"Abstract":[0],"Objective.":[1],"Consequently,":[2],"activation":[3],"of":[4,15,45,50,55,69,131,175,237,261,402,479,494,509,572,611,653,664,693],"the":[5,13,48,53,87,101,107,158,169,201,290,334,424,436,492,543,569,627,634,657,661,688],"Jak-STAT":[6],"pathway":[7],"plays":[8],"a":[9,43,74,97,123,215,476,507,589,594,671],"central":[10],"role":[11],"in":[12,42,61,141,157,327,423,435,445,452,486,497,568,678],"pathogenesis":[14],"primary":[16],"myelofibrosis":[17,498,513,548,582],"and":[18,92,126,172,204,284,299,412,449,481,503,514,537,549,584,625,660,691],"resulting":[19],"profound":[20],"chronic":[21],"inflammation.":[22],"The":[23,129,400,651],"Neutrophil-to-Lymphocyte":[24],"Ratio":[25],"(NLR)":[26],"is":[27,475,499,670],"an":[28,83],"inflammatory":[29],"biomarker":[30,478],"that,":[31],"whose":[32],"elevation,":[33],"has":[34],"been":[35],"consistently":[36],"associated":[37,314,342,463,483,643],"with":[38,63,146,315,343,464,512,532,547,558,588,599,633,644],"poor":[39],"clinical":[40],"outcomes":[41],"variety":[44],"malignancies.":[46],"However,":[47,491,680],"results":[49,68],"studies":[51,685],"investigating":[52],"effect":[54],"NLR":[56,138,279,303,338,414,426,438,447,454,460,471,474,496,520,533,538,551,560,591,600,612,629,641,669],"on":[57,73],"overall":[58,273,554],"survival":[59,212,226,274,522,555,619],"(OS)":[60],"patients":[62,165,240,255,294,421,433,511,529,546,557,583,587,598],"PMF":[64,142,239],"remain":[65],"conflicting.":[66],"Preliminary":[67],"this":[70,132],"study,":[71,605],"based":[72],"smaller":[75],"patient":[76,115],"cohort":[77,116,508],"(n=72),":[78],"were":[79,93,154,166,179,192,198,230,241,247,256,263,311,331,340,396,462],"previously":[80],"presented":[81],"as":[82,96,214,289],"oral":[84],"presentation":[85,99],"at":[86,100,168],"12th":[88],"SOHO":[89,102],"Turkiye":[90],"Meeting":[91],"later":[94],"accepted":[95],"poster":[98],"2025":[103],"Annual":[104],"Meeting.":[105],"In":[106,456,542,603],"current":[108],"analysis,":[109,527],"we":[110,606,681],"have":[111],"significantly":[112,313,409,465,645],"expanded":[113],"our":[114,457,604,654],"to":[117,121,135,162,220,431,615,686],"128,":[118],"enabling":[119],"us":[120],"perform":[122],"more":[124],"comprehensive":[125],"robust":[127],"evaluation.":[128],"aim":[130],"study":[133,566,655],"was":[134,218,251,269,275,280,442,642],"determine":[136,221],"how":[137],"predicts":[139],"OS":[140,441,468,596,647,677],"patients.":[143],"Methodology.":[144],"Patients":[145],"diagnosis":[147],"Primary":[148],"Myelofibrosis":[149],"fulfilling":[150],"WHO":[151],"2016":[152],"criteria":[153],"retrospectively":[155,505],"analysed":[156,506,578],"period":[159],"from":[160,181,307,580],"2011":[161],"2024.":[163],"All":[164,177],"registered":[167],"National":[170],"Hematology":[171],"Transfusion":[173],"Center":[174],"Azerbaijan.":[176],"data":[178,579],"collected":[180],"medical":[182],"records.":[183],"Mann-Whitney":[184],"U":[185],"test,":[186,188],"Kruskal-Wallis":[187],"\u03c72":[189],"(chi-squared)":[190],"test":[191],"used":[193],"where":[194],"appropriate.":[195],"Survival":[196],"analyses":[197,523],"performed":[199,219],"using":[200,211,524,621],"Kaplan-Meier":[202],"method":[203],"Cox":[205],"regression":[206],"analysis.":[207],"ROC":[208,285,525,622],"curve":[209,526,623],"analysis":[210,286,620,624],"status":[213],"classification":[216],"variable":[217],"optimal":[222,291,516,608],"cut-off":[223,517,609,690],"values":[224,310,339,461,518,610],"for":[225,519,521,618,675],"analyses.":[227],"p-values":[228],"<0.05":[229],"considered":[231],"statistically":[232,312,398],"significant.":[233,399],"Results.":[234],"A":[235],"total":[236],"128":[238],"evaluated.":[242],"Of":[243],"these,":[244],"60":[245],"(46.87%)":[246],"male.":[248],"Median":[249,267,272,278,440],"age":[250,345],"59":[252],"years,":[253],"27(21.09%)":[254],"young(under":[257],"50":[258],"years).":[259],"Majority":[260],"pateints":[262],"JAK2V617F":[264],"mutated":[265],"(75%).":[266],"follow-up":[268],"37.16":[270],"months.":[271,277],"131":[276,443],"4.2":[281],"(IQR":[282],"4.4),":[283],"identified":[287,607],"2.1":[288],"cut-off,":[292],"dividing":[293],"into":[295,530],"high":[296,350,361,425,453,459,628],"(>2.1,":[297],"N=105)":[298],"low":[300,437,446,470,635],"(\u22642.1,":[301],"N=23)":[302],"groups.":[304,336],"As":[305],"expected":[306],"NLR,":[308],"higher":[309,316,320,372,550,640],"WBC":[317],"count":[318,323,330,363],"(p<0.001),":[319],"absolute":[321,328],"neutrophil":[322],"(p<0.001).":[324],"No":[325],"differences":[326],"lymphocyte":[329],"observed":[332],"between":[333,410],"two":[335],"Higher":[337],"also":[341],"older":[344],"(57":[346],"vs":[347,356,367,378,389,469],"55;":[348],"p-0.768),":[349],"Hgb":[351],"levels":[352],"(11.75":[353],"IQR":[354,358,365,369,376,380,387,391],"4.4":[355],"9.6":[357],"3.65:":[359],"p-0.13),":[360],"platelet":[362],"(359.0":[364],"386":[366],"280.0":[368],"368;":[370],"p=0.12),":[371],"LDH":[373],"level":[374],"(503.0":[375],"487":[377],"446.0":[379],"177.5;":[381],"p=0.628),":[382],"lower":[383,559,649],"MPN":[384],"TSS":[385],"(10.5":[386],"13.75":[388],"21.0":[390],"13.5;":[392],"p=0.068),":[393],"but":[394],"they":[395],"not":[397,407],"distribution":[401],"IPSS":[403],"risk":[404],"categories":[405],"did":[406],"differ":[408],"High":[411],"Low":[413],"groups":[415,531],"(p=0.839).":[416],"At":[417],"last":[418],"follow-up,":[419],"11":[420],"(10.5%)":[422],"group":[427,448,632],"had":[428,552,593],"died":[429],"compared":[430,626],"9":[432],"(39.1%)":[434],"group.":[439,455],"month":[444],"doesn\u2032t":[450],"reach":[451],"cohort,":[458],"better":[466,646],"median":[467],"(p-0.008).":[472],"Conclusion.":[473],"simple":[477],"inflammation":[480],"its":[482],"worse":[484],"outcome":[485],"various":[487],"malignancies":[488],"when":[489],"elevated.":[490],"association":[493],"elevated":[495],"controversial.":[500],"M.":[501],"Lucijanic":[502],"colleagues":[504],"102":[510],"determined":[515],"separating":[528],"\u226510":[534],"(higher":[535],"NLR)":[536],"<10":[539],"(lower":[540],"NLR).":[541],"univariate":[544],"analyses,":[545],"shorter":[553],"than":[556,597,648],"(HR=2.05;":[561],"p=0.030)":[562],".":[563,602],"Another":[564],"retrospective":[565,658],"published":[567],"European":[570],"Journal":[571],"Haematology":[573],"by":[574],"Lagan\u00e0":[575],"et":[576],"al.":[577],"140":[581],"found":[585],"that":[586,639,668],"baseline":[590],"\u22652":[592],"longer":[595],"<2":[601],"2.1-":[613],"similar":[614],"previous":[616],"as-":[617],"(":[630],">2.1)":[631],"NLR.":[636,694],"We":[637,666],"showed":[638],"NLR(p-0.008).":[650],"limitations":[652],"are":[656],"design":[659],"small":[662],"number":[663],"participants.":[665],"believe":[667],"valuable":[672],"prognostic":[673],"factor":[674],"predicting":[676],"PMF.":[679],"need":[682],"large":[683],"prospective":[684],"define":[687],"exact":[689],"impact":[692]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-12-04T00:00:00"}